871 related articles for article (PubMed ID: 11559564)
21. Topoisomerase I and II inhibitors control caspase-2 pre-messenger RNA splicing in human cells.
Solier S; Lansiaux A; Logette E; Wu J; Soret J; Tazi J; Bailly C; Desoche L; Solary E; Corcos L
Mol Cancer Res; 2004 Jan; 2(1):53-61. PubMed ID: 14757846
[TBL] [Abstract][Full Text] [Related]
22. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
[TBL] [Abstract][Full Text] [Related]
23. SR-related proteins and the processing of messenger RNA precursors.
Blencowe BJ; Bowman JA; McCracken S; Rosonina E
Biochem Cell Biol; 1999; 77(4):277-91. PubMed ID: 10546891
[TBL] [Abstract][Full Text] [Related]
24. Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA.
Kanopka A; Mühlemann O; Akusjärvi G
Nature; 1996 Jun; 381(6582):535-8. PubMed ID: 8632829
[TBL] [Abstract][Full Text] [Related]
25. Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents.
Bailly C; Dassonneville L; Colson P; Houssier C; Fukasawa K; Nishimura S; Yoshinari T
Cancer Res; 1999 Jun; 59(12):2853-60. PubMed ID: 10383146
[TBL] [Abstract][Full Text] [Related]
26. A DNA binding indolocarbazole disaccharide derivative remains highly cytotoxic without inhibiting topoisomerase I.
Qu X; Chaires JB; Ohkubo M; Yoshinari T; Nishimura S; Bailly C
Anticancer Drug Des; 1999 Oct; 14(5):433-42. PubMed ID: 10766298
[TBL] [Abstract][Full Text] [Related]
27. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
[TBL] [Abstract][Full Text] [Related]
28. PSKH1, a novel splice factor compartment-associated serine kinase.
Brede G; Solheim J; Prydz H
Nucleic Acids Res; 2002 Dec; 30(23):5301-9. PubMed ID: 12466556
[TBL] [Abstract][Full Text] [Related]
29. XE7: a novel splicing factor that interacts with ASF/SF2 and ZNF265.
Mangs AH; Speirs HJ; Goy C; Adams DJ; Markus MA; Morris BJ
Nucleic Acids Res; 2006; 34(17):4976-86. PubMed ID: 16982639
[TBL] [Abstract][Full Text] [Related]
30. Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site.
Urasaki Y; Laco G; Takebayashi Y; Bailly C; Kohlhagen G; Pommier Y
Cancer Res; 2001 Jan; 61(2):504-8. PubMed ID: 11212241
[TBL] [Abstract][Full Text] [Related]
31. Novel antitumor indolocarbazole compound 6-N-formylamino-12,13-dihydro-1,11- dihydroxy-13-(beta-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo[3,4- c]carbazole-5,7(6H)-dione (NB-506): induction of topoisomerase I-mediated DNA cleavage and mechanisms of cell line-selective cytotoxicity.
Yoshinari T; Matsumoto M; Arakawa H; Okada H; Noguchi K; Suda H; Okura A; Nishimura S
Cancer Res; 1995 Mar; 55(6):1310-5. PubMed ID: 7882328
[TBL] [Abstract][Full Text] [Related]
32. Thiophosphorylation of U1-70K protein inhibits pre-mRNA splicing.
Tazi J; Kornstädt U; Rossi F; Jeanteur P; Cathala G; Brunel C; Lührmann R
Nature; 1993 May; 363(6426):283-6. PubMed ID: 8387646
[TBL] [Abstract][Full Text] [Related]
33. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.
Jumaa H; Nielsen PJ
EMBO J; 1997 Aug; 16(16):5077-85. PubMed ID: 9305649
[TBL] [Abstract][Full Text] [Related]
34. The splicing factor ASF/SF2 is associated with TIA-1-related/TIA-1-containing ribonucleoproteic complexes and contributes to post-transcriptional repression of gene expression.
Delestienne N; Wauquier C; Soin R; Dierick JF; Gueydan C; Kruys V
FEBS J; 2010 Jun; 277(11):2496-514. PubMed ID: 20477871
[TBL] [Abstract][Full Text] [Related]
35. A molecular link between SR protein dephosphorylation and mRNA export.
Huang Y; Yario TA; Steitz JA
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9666-70. PubMed ID: 15210956
[TBL] [Abstract][Full Text] [Related]
36. Small molecule inhibitors of yeast pre-mRNA splicing.
Aukema KG; Chohan KK; Plourde GL; Reimer KB; Rader SD
ACS Chem Biol; 2009 Sep; 4(9):759-68. PubMed ID: 19634919
[TBL] [Abstract][Full Text] [Related]
37. SR protein kinases: the splice of life.
Stojdl DF; Bell JC
Biochem Cell Biol; 1999; 77(4):293-8. PubMed ID: 10546892
[TBL] [Abstract][Full Text] [Related]
38. Expression of splicing factors in human ovarian cancer.
Fischer DC; Noack K; Runnebaum IB; Watermann DO; Kieback DG; Stamm S; Stickeler E
Oncol Rep; 2004 May; 11(5):1085-90. PubMed ID: 15069551
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of pre-mRNA splicing by cisplatin and platinum analogs.
Schmittgen TD; Ju JF; Danenberg KD; Danenberg PV
Int J Oncol; 2003 Sep; 23(3):785-9. PubMed ID: 12888918
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional co-activator protein p100 interacts with snRNP proteins and facilitates the assembly of the spliceosome.
Yang J; Välineva T; Hong J; Bu T; Yao Z; Jensen ON; Frilander MJ; Silvennoinen O
Nucleic Acids Res; 2007; 35(13):4485-94. PubMed ID: 17576664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
